Evidence map›Paper›PMID 27818326›Full record

ReviewChest2017

An Update on Lymphocyte Subtypes in Asthma and Airway Disease.

Daniel M Moldaver, Mark Larché, Christopher D Rudulier

Abstract readReview
In one paragraph

Review in Chest, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Single-cell RNA-sequencing in asthma research.Frontiers in immunology · 2022
    Review
  10. Th17 Lymphocytes in Children with Asthma: Do They Influence Control?Pediatric allergy, immunology, and pulmonology · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Acupuncture Regulates the Balance of CD4Chinese journal of integrative medicine · 2019
    Article
  16. Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daniel M MoldaverFirestone Institute for Respiratory Health, St. Joseph's Hospital Healthcare, Divisions of Clinical Immunology & Allergy and Respirology, Department of Medicine, McMaster University, Hamilton, ON.
Mark LarchéFirestone Institute for Respiratory Health, St. Joseph's Hospital Healthcare, Divisions of Clinical Immunology & Allergy and Respirology, Department of Medicine, McMaster University, Hamilton, ON. Electronic address: larche@mcmaster.ca.
Christopher D RudulierDivision of Respirology, Critical Care and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.

Funding

The effect of peptide therapy and allergen provocation on Fel d1-specific T CellsU19AI100266 · NIAID · MCMASTER UNIVERSITY · PI LARCHE, MARK · 2012 to 2018
$6.5M
NIAID NIH HHS U19 AI100266
6 · The paper itself

Abstract

Inflammation is a hallmark of many airway diseases. Improved understanding of the cellular and molecular mechanisms of airway disease will facilitate the transition in our understanding from phenotypes to endotypes, thereby improving our ability to target treatments based on pathophysiologic characteristics. For example, allergic asthma has long been considered to be driven by an allergen-specific T helper 2 response. However, clinical and mechanistic studies have begun to shed light on the role of other cell subsets in the pathogenesis and regulation of lung inflammation. In this review, we discuss the importance of different lymphocyte subsets to asthma and other airway diseases, while highlighting the growing evidence that asthma is a syndrome that incorporates many immune phenotypes.

Indexed as

AllergensAsthmaB-LymphocytesHumansInflammationInterleukin-22Interleukin-9InterleukinsLymphocytesTh17 CellsTh2 CellsT-Lymphocytes, Helper-InducerT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsAllergensIL9 protein, humanInterleukin-22Interleukin-9InterleukinsILC2iTr35TfhTh1Th2Th22

Identifiers

PMID27818326
PMCPMC6026230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.